Follow the people · Insider

YM

Yann Mazabraud

Insider · EVP, Head of International · RYTM

Yann Mazabraud files insider transactions with the SEC as an evp, head of international of Rhythm Pharmaceuticals (RYTM). We hold 1 disclosed purchase or sale filed since 5 June 2019, 1 of them in the last 90 days.

  • Files forRYTM
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure14 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 5 October 202012 August 2026EVP, Head of International · Rhythm Pharmaceuticals (RYTM)73 Form 4 lines · source: SEC Form 4
  • Filed 3 June 201913 February 2020Officer · Trevi Therapeutics (TRVI)2 Form 4 lines · source: SEC Form 4

Everything they disclosed

75 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.